Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on long-term use in type 2 diabetes mellitus patients with renal or hepatic impairment or advanced age"
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 15 Nov 2018
Price : $35 *
At a glance
- Drugs Alogliptin/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Takeda Pharma
- 06 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 23 Jul 2018 Planned End Date changed from 30 Jun 2019 to 31 Oct 2019.
- 23 Jul 2018 Planned primary completion date changed from 30 Jun 2019 to 31 Oct 2019.